We are live on
!
Find out more
B
Barings Portfolio holdings
AUM
$5.64B
1-Year Est. Return
18.33%
This Fund
S&P 500
This Quarter
Est. Return
+0.34%
1 Year Est. Return
+18.33%
3 Year Est. Return
+58.28%
5 Year Est. Return
+58.55%
10 Year Est. Return
+305.55%
AUM
$3.31B
AUM Growth
-$1.06B
(-24%)
Cap. Flow
-$246M
Cap. Flow
% of AUM
-7.45%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
1,106
New
139
Increased
321
Reduced
276
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AEUA
Anadarko Petroleum Corporation
AEUA
|
+$18.2M |
| 2 |
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$15M |
| 3 |
Gilead Sciences
GILD
|
+$10.2M |
| 4 |
Home Depot
HD
|
+$9.33M |
| 5 |
Merck
MRK
|
+$9.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$11M |
| 2 |
Johnson & Johnson
JNJ
|
+$8.24M |
| 3 |
Union Pacific
UNP
|
+$6.72M |
| 4 |
Metallus
MTUS
|
+$6.41M |
| 5 |
XLS
EXELIS INC COM STK
XLS
|
+$6.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.23% |
| 2 | Technology | 9.28% |
| 3 | Healthcare | 9.19% |
| 4 | Financials | 9.19% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Colgate-Palmolive
CL
$69.7B
| $1.2M | 0.04% |
18,342
+6,000
| +49% | +$407K |
|
427
RPM International
RPM
$12.9B
| $1.2M | 0.04% |
24,470
| – | – |
|
428
Consolidated Edison
ED
$39.1B
| $1.2M | 0.04% |
20,651
| – | – |
|
429
Analog Devices
ADI
$177B
| $1.19M | 0.04% |
18,593
+500
| +3% | +$32.4K |
|
430
Canadian Natural Resources
CNQ
$103B
| $1.19M | 0.04% |
90,520
| – | – |
|
431
Progressive
PGR
$128B
| $1.19M | 0.04% |
42,648
-59,300
| -58% | -$1.62M |
|
|
SIAL
432
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $1.18M | 0.04% |
8,495
| – | – |
|
|
GAP
433
The Gap Inc
GAP
$7.26B
| $1.18M | 0.04% |
30,995
+700
| +2% | +$27.6K |
|
434
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.2B
| $1.18M | 0.04% |
30,800
+13,400
| +77% | +$513K |
|
435
Charles River Laboratories
CRL
$13.3B
| $1.18M | 0.04% |
16,700
+13,100
| +364% | +$969K |
|
436
MSCI
MSCI
$39.7B
| $1.17M | 0.04% |
+19,000
| New | +$1.18M |
|
|
VR
437
DELISTED
Validus Hold Ltd
VR
| $1.17M | 0.04% |
26,500
-5,400
| -17% | -$232K |
|
|
ENH
438
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $1.16M | 0.03% |
17,600
-3,700
| -17% | -$230K |
|
439
Omnicom Group
OMC
$21.9B
| $1.15M | 0.03% |
16,545
| – | – |
|
|
OCR
440
DELISTED
OMNICARE INC
OCR
| $1.15M | 0.03% |
12,200
+5,800
| +91% | +$517K |
|
441
Cadence Design Systems
CDNS
$77.2B
| $1.14M | 0.03% |
58,000
+20,100
| +53% | +$390K |
|
|
BRCD
442
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $1.14M | 0.03% |
95,500
+36,900
| +63% | +$448K |
|
443
FirstEnergy
FE
$26.4B
| $1.13M | 0.03% |
34,850
+9,900
| +40% | +$346K |
|
444
Everest Group
EG
$14.5B
| $1.13M | 0.03% |
6,220
+2,680
| +76% | +$488K |
|
|
SCG
445
DELISTED
Scana
SCG
| $1.13M | 0.03% |
22,320
| – | – |
|
446
Invesco
IVZ
$13.6B
| $1.13M | 0.03% |
30,135
+10,200
| +51% | +$408K |
|
447
Voya Financial
VOYA
$9.25B
| $1.13M | 0.03% |
24,300
+18,800
| +342% | +$847K |
|
448
Clean Energy Fuels
CLNE
$373M
| $1.12M | 0.03% |
200,000
| – | – |
|
449
C.H. Robinson
CHRW
$18B
| $1.12M | 0.03% |
17,974
| – | – |
|
450
Gen Digital
GEN
$18.4B
| $1.12M | 0.03% |
48,134
+8,800
| +22% | +$215K |
|
Similar funds
VH
TAM
KCM
DSC
CS
LP
ASC
CBUSF
Barings's Q2 2015 Portfolio in Review
As of Q2 2015, Barings held 1,106 positions worth $3.31B, down 24% from $4.37B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barings withdrew a net $246M in Q2 2015, closing 134 positions and reducing 276 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $11M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Barings opened a new position in Anadarko Petroleum Corporation worth $18.1M.
- Barings's largest Q2 2015 buy was Anadarko Petroleum Corporation: 360,000 shares worth $18.1M.
- Barings added most to Gilead Sciences in Q2 2015, an estimated $10.2M increase.
- Barings's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $8.24M.
- Barings fully exited iShares Russell 1000 Growth ETF in Q2 2015, selling an estimated $11M.
- Barings's ten largest holdings make up 27% of its $3.31B portfolio in Q2 2015.
- Barings opened 139 new positions and closed 134 in Q2 2015.
- Barings's portfolio value fell 24% quarter-over-quarter to $3.31B.
Based on Barings's 13F filing for Q2 2015, filed 14 Aug 2015.